Interleukin 12 Receptor Market, Global Outlook and Forecast 2022-2028

Interleukin 12 Receptor Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281251 | No. of Pages: 67 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Interleukin 12 Receptor in Global, including the following market information:
Global Interleukin 12 Receptor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Interleukin 12 Receptor market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Edodekin Alfa SR Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interleukin 12 Receptor include Eli Lilly and Company, Mallinckrodt Plc, Merck KGaA and Neumedicines Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interleukin 12 Receptor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interleukin 12 Receptor Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Interleukin 12 Receptor Market Segment Percentages, by Type, 2021 (%)
    Edodekin Alfa SR
    M-9241
    LY-3232094
    NMIL-121
    Others
Global Interleukin 12 Receptor Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Interleukin 12 Receptor Market Segment Percentages, by Application, 2021 (%)
    In-Patient
    Out-Patient
Global Interleukin 12 Receptor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Interleukin 12 Receptor Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interleukin 12 Receptor revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Interleukin 12 Receptor revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Eli Lilly and Company
    Mallinckrodt Plc
    Merck KGaA
    Neumedicines Inc
1 Introduction to Research & Analysis Reports
    1.1 Interleukin 12 Receptor Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Interleukin 12 Receptor Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Interleukin 12 Receptor Overall Market Size
    2.1 Global Interleukin 12 Receptor Market Size: 2021 VS 2028
    2.2 Global Interleukin 12 Receptor Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Interleukin 12 Receptor Players in Global Market
    3.2 Top Global Interleukin 12 Receptor Companies Ranked by Revenue
    3.3 Global Interleukin 12 Receptor Revenue by Companies
    3.4 Top 3 and Top 5 Interleukin 12 Receptor Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Interleukin 12 Receptor Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Interleukin 12 Receptor Players in Global Market
        3.6.1 List of Global Tier 1 Interleukin 12 Receptor Companies
        3.6.2 List of Global Tier 2 and Tier 3 Interleukin 12 Receptor Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Interleukin 12 Receptor Market Size Markets, 2021 & 2028
        4.1.2 Edodekin Alfa SR
        4.1.3 M-9241
        4.1.4 LY-3232094
        4.1.5 NMIL-121
        4.1.6 Others
    4.2 By Type - Global Interleukin 12 Receptor Revenue & Forecasts
        4.2.1 By Type - Global Interleukin 12 Receptor Revenue, 2017-2022
        4.2.2 By Type - Global Interleukin 12 Receptor Revenue, 2023-2028
        4.2.3 By Type - Global Interleukin 12 Receptor Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Interleukin 12 Receptor Market Size, 2021 & 2028
        5.1.2 In-Patient
        5.1.3 Out-Patient
    5.2 By Application - Global Interleukin 12 Receptor Revenue & Forecasts
        5.2.1 By Application - Global Interleukin 12 Receptor Revenue, 2017-2022
        5.2.2 By Application - Global Interleukin 12 Receptor Revenue, 2023-2028
        5.2.3 By Application - Global Interleukin 12 Receptor Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Interleukin 12 Receptor Market Size, 2021 & 2028
    6.2 By Region - Global Interleukin 12 Receptor Revenue & Forecasts
        6.2.1 By Region - Global Interleukin 12 Receptor Revenue, 2017-2022
        6.2.2 By Region - Global Interleukin 12 Receptor Revenue, 2023-2028
        6.2.3 By Region - Global Interleukin 12 Receptor Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Interleukin 12 Receptor Revenue, 2017-2028
        6.3.2 US Interleukin 12 Receptor Market Size, 2017-2028
        6.3.3 Canada Interleukin 12 Receptor Market Size, 2017-2028
        6.3.4 Mexico Interleukin 12 Receptor Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Interleukin 12 Receptor Revenue, 2017-2028
        6.4.2 Germany Interleukin 12 Receptor Market Size, 2017-2028
        6.4.3 France Interleukin 12 Receptor Market Size, 2017-2028
        6.4.4 U.K. Interleukin 12 Receptor Market Size, 2017-2028
        6.4.5 Italy Interleukin 12 Receptor Market Size, 2017-2028
        6.4.6 Russia Interleukin 12 Receptor Market Size, 2017-2028
        6.4.7 Nordic Countries Interleukin 12 Receptor Market Size, 2017-2028
        6.4.8 Benelux Interleukin 12 Receptor Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Interleukin 12 Receptor Revenue, 2017-2028
        6.5.2 China Interleukin 12 Receptor Market Size, 2017-2028
        6.5.3 Japan Interleukin 12 Receptor Market Size, 2017-2028
        6.5.4 South Korea Interleukin 12 Receptor Market Size, 2017-2028
        6.5.5 Southeast Asia Interleukin 12 Receptor Market Size, 2017-2028
        6.5.6 India Interleukin 12 Receptor Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Interleukin 12 Receptor Revenue, 2017-2028
        6.6.2 Brazil Interleukin 12 Receptor Market Size, 2017-2028
        6.6.3 Argentina Interleukin 12 Receptor Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Interleukin 12 Receptor Revenue, 2017-2028
        6.7.2 Turkey Interleukin 12 Receptor Market Size, 2017-2028
        6.7.3 Israel Interleukin 12 Receptor Market Size, 2017-2028
        6.7.4 Saudi Arabia Interleukin 12 Receptor Market Size, 2017-2028
        6.7.5 UAE Interleukin 12 Receptor Market Size, 2017-2028
7 Players Profiles
    7.1 Eli Lilly and Company
        7.1.1 Eli Lilly and Company Corporate Summary
        7.1.2 Eli Lilly and Company Business Overview
        7.1.3 Eli Lilly and Company Interleukin 12 Receptor Major Product Offerings
        7.1.4 Eli Lilly and Company Interleukin 12 Receptor Revenue in Global Market (2017-2022)
        7.1.5 Eli Lilly and Company Key News
    7.2 Mallinckrodt Plc
        7.2.1 Mallinckrodt Plc Corporate Summary
        7.2.2 Mallinckrodt Plc Business Overview
        7.2.3 Mallinckrodt Plc Interleukin 12 Receptor Major Product Offerings
        7.2.4 Mallinckrodt Plc Interleukin 12 Receptor Revenue in Global Market (2017-2022)
        7.2.5 Mallinckrodt Plc Key News
    7.3 Merck KGaA
        7.3.1 Merck KGaA Corporate Summary
        7.3.2 Merck KGaA Business Overview
        7.3.3 Merck KGaA Interleukin 12 Receptor Major Product Offerings
        7.3.4 Merck KGaA Interleukin 12 Receptor Revenue in Global Market (2017-2022)
        7.3.5 Merck KGaA Key News
    7.4 Neumedicines Inc
        7.4.1 Neumedicines Inc Corporate Summary
        7.4.2 Neumedicines Inc Business Overview
        7.4.3 Neumedicines Inc Interleukin 12 Receptor Major Product Offerings
        7.4.4 Neumedicines Inc Interleukin 12 Receptor Revenue in Global Market (2017-2022)
        7.4.5 Neumedicines Inc Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com